AN DIEGO, Feb. 1, 2017 — Medical Marijuana, Inc. (otc pink:MJNA), the first publicly traded cannabis company in the United States, announced today that its subsidiary HempMeds® Brasil has begun the process of importing its Real Scientific Hemp Oil™ (RSHO) Green Label into Brazil.
HempMeds® Brasil is the first company to offer legal medical cannabis products to Brazil after receiving approval to import to those suffering from specific medical conditions. RSHO™ is a natural, full-spectrum CBD oil extracted from hemp plants grown in Northern Europe. The RSHO™ Green Label contains a high concentration of cannabinoids in their acidic form – Cannabidiolic Acid. This product is an integral “juice” or extract of the plant that HempMeds® grows.
“We are proud to announce the import of RSHO™ Green Label to the people of Brazil,” said Medical Marijuana, Inc. CEO, Dr. Stuart Titus. “The introduction of this product in Brazil signals a huge step forward for those in need of medicinal relief and those who continue to suffer at the hands of inadequate restorative aid. Our company has, and will, continue to be driven by the idea that the interests of people come before profit models. From athletes, to around-the-clock business owners, to children as well as the elderly, we see the potential for an overwhelmingly positive affect on the lives of millions within the country. I am firmly confident in the potential and future of our product within the country of Brazil.”
Due to the minimal processing, RSHO™ Green Label has the lowest price point of any other RSHO™ lines. For more product information be sure to click HERE.
About HempMeds® Brasil HempMeds® Brasil currently has three cannabis products approved for importation into Brazil as a prescription medication for Epilepsy, Parkinson’s and Chronic Pain. The company had the first-ever cannabis product allowed for import into Brazil and its products are currently subsidized by the Brazilian government, under their health care system, for all three medical indications listed above. HempMeds® Brasil is working on additional approvals for multiple indications.
About Medical Marijuana, Inc.Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
FORWARD-LOOKING DISCLAIMER This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
LEGAL DISCLOSURE Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.